Tags » U-S-securities-and-exchange-commission

U.S. securities commission probes Exxon's climate, reserves accounting: report

The U.S. Securities and Exchange Commission is investigating how Exxon Mobil Corp has valued its reserves in the wake of low oil prices and potential curbs on carbon emissions, the Wall Street Journal reported on Tuesday, citing people familiar with the matter. 362 more words

Energy

How Fiat Chrysler star exec Reid Bigland landed at the centre of a U.S. criminal probe of auto sales

This should’ve been Reid Bigland’s year.

Under his leadership, Fiat Chrysler Automobiles outsold its competitors in Canada for the first time in the carmaker’s history while enjoying an unprecedented streak of rising sales in the U.S. 1,572 more words

Transportation

Tesla Gets $300 Million Credit Line From Deutsche Bank

Tesla can borrow up to $300 million for its vehicle leasing program through an agreement with Deutsche Bank as part of a broader effort to bolster the company’s finances. 262 more words

Tech

Employers need to take a look at the OSC's whistleblower program

The Toronto International Film Festival kicks off this week, and one of the big Hollywood films on offer is Oliver Stone’s political thriller about whistleblower Edward Snowden. 761 more words

Legal Post

Royal Bank of Canada to pay SEC US$2.5-million fine over false disclosure in Warburg Pincus deal

Royal Bank of Canada agreed to pay US$2.5 million to settle U.S. Securities and Exchange Commission allegations that its valuation of an ambulance-provider in 2011 was too low, making a Warburg Pincus takeover offer look more attractive. 197 more words

FP Street

Five things you should know before you start your workday on Aug. 31

Good morning. The possible future for Canadian fertilizer companies. The U.S. Securities and Exchange Commission awards the Monsanto whistleblower US$22 million. And why Ireland doesn’t want Apple’s US$14.5 billion in back taxes. 799 more words

Executive

Valeant accused of racketeering in class-action lawsuit from N.Y. health funds

Valeant Pharmaceuticals is being sued by New York health benefit funds providers that allege the embattled Canadian drug manufacturer overcharged for medications in contravention of racketeering and consumer-protection legislation. 382 more words

Business